Weight
Loss.
Sustainable weight loss, evidence-first — what diet, movement, and sleep actually do for appetite, satiety, and lasting results.
Natural GLP-1 Boosters: Foods and Supplements That Mimic Ozempic
Which foods and supplements actually raise your body's own GLP-1, what the human evidence supports, and why none of it replaces a prescription drug.
Photograph · HL BenefitsThe latest, in long form.
Browse all 46 →
Survodutide: How the Glucagon + GLP-1 Drug Burns Fat Differently
Survodutide activates both glucagon and GLP-1 receptors, adding fat oxidation and energy expenditure to appetite suppression. Phase 2 showed ~19% weight loss.
Oral GLP-1 Pills: Everything You Need to Know About the Wegovy Pill
Weight LossMedicare GLP-1 Coverage in 2026: The Bridge Program and What Seniors Need to Know
Weight LossGLP-1 and Menopause: Weight Loss Solutions for Women Over 40
GLP-1 Weight Regain After Stopping: What the Data Actually Shows
A meta-analysis of 18 trials found 5.63 kg average weight regain after stopping GLP-1 drugs, but real-world data from 188K patients shows 56% sustain some loss at 2 years.
GLP-1 Drug Costs and Access: Insurance, Compounding, and Affordability in 2026
From $1,349 list prices to $25 copays, GLP-1 drug costs depend on which programs you use. Here is what works now.
How Long Do You Stay on GLP-1 Drugs? The Lifetime Question
The WHO recommends long-term GLP-1 use for obesity. But only 4-year data exists, and half of patients stop by year one. What the research says about the forever drug question.
Companion sections.
All sections →Health
A companion section to weight loss, with its own evidence-led reading list.
Food & Nutrition
A companion section to weight loss, with its own evidence-led reading list.
Fitness
A companion section to weight loss, with its own evidence-led reading list.
Definitive guides.
All guides →
Your First Month on Ozempic: A Week-by-Week Guide
A week-by-week breakdown of your first month on Ozempic, covering dose titration, side effect management, eating strategies, and when to call your doctor.
Amycretin: The GLP-1 + Amylin Drug Showing 25%+ Weight Loss
Novo Nordisk's amycretin produced 24.3% weight loss in 36 weeks by combining GLP-1 and amylin agonism in a single molecule. Phase 3 trials begin 2026.
On our desk this week.
More from the desk →
CagriSema: Novo Nordisk's Next-Generation Obesity Drug Explained
CagriSema pairs GLP-1 with amylin for 22.7% weight loss. NDA filed, FDA decision expected late 2026.
Peptides for Stubborn Menopausal Belly Fat: The Tesamorelin Conversation Continues
Visceral fat doubles during menopause. Tesamorelin has clinical data for reduction, but all trials are in HIV patients. What menopausal women should know.
Quick reads.
All 46 →Tirzepatide vs. Semaglutide: Which GLP-1 Peptide Actually Melts More Fat?
SURMOUNT-5 settled the indirect-comparison era. Here is what the head-to-head trial…
The 7 Most Effective Weight Loss Peptides Doctors Are Quietly Recommending in 2026
From semaglutide to retatrutide and tesamorelin: the seven peptides reshaping obesity…
The Stubborn Belly Fat Peptide: Why Tesamorelin Is Going Viral with Women Over 40
Tesamorelin is trending as a midlife belly-fat peptide, but the FDA approval, the 18%…
Hit an Ozempic Plateau? 5 Peptide Stacks That May Restart Stalled Weight Loss
Plateaus on GLP-1 drugs are biology, not failure. Here is an evidence-honest review of…
I Tried Semaglutide for 90 Days: The Honest Before-and-After Nobody Talks About
What 90 days of semaglutide actually changes — pulled from STEP-1, STEP-4, and…
Retatrutide Is Being Called the "Godzilla" of Weight Loss — Here's What Phase 3 Trials Just Revealed
Retatrutide produced 28.7% mean weight loss in its first Phase 3 readout. Here's what…
GLP-1 Microdosing: The Quiet Trend Replacing Full-Dose Ozempic in 2026
GLP-1 microdosing is everywhere in 2026. Here is what the evidence actually shows about…
Compounded Semaglutide: How to Tell a Safe Source from a Dangerous Knockoff
After the FDA declared the semaglutide shortage resolved in February 2025, the legal…
From the archive.
All 46 →
AOD-9604: The 'Fat-Burning Fragment' That Promises Results Without Hunger Loss
Tirzepatide vs Semaglutide (Mounjaro/Zepbound vs Ozempic/Wegovy): Complete Comparison
Retatrutide: The Triple-Agonist Weight Loss Drug Showing 24-29% Body Weight Reduction
Oral Semaglutide (Rybelsus / Wegovy Pill): The End of Weight Loss Injections?
Ozempic Face: Why It Happens, How to Prevent It, and Treatment Options
Facial volume loss from rapid GLP-1 weight loss affects millions. Evidence-based strategies to protect your face while losing weight.
The Gelatin Trick for Weight Loss: Does Science Support This Viral Hack?
Research shows gelatin suppresses appetite 44% more than casein short-term, but long-term weight loss trials tell a different story.
How to Prevent Muscle Loss on GLP-1 Medications
Evidence-based strategies to preserve muscle mass on semaglutide and tirzepatide, including resistance training protocols and protein targets.
How Cortisol Drives Weight Gain and What Actually Helps
Chronic stress raises cortisol levels that drive belly fat storage, disrupt hunger signals, and break down muscle. Evidence-based strategies can help.
CLA Safflower Oil Reviews: What the Research Actually Shows
Clinical research shows CLA safflower oil produces about 90 grams of fat loss per week, targets the wrong kind of fat, and carries insulin resistance risks.
Weight Loss Supplements for Women Over 40: What the Research Says
Which weight loss supplements actually work for women over 40? Evidence on berberine, green tea extract, probiotics, and magnesium.